Kathleen P Pratt

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 12

Top Venues

Blood

Antibodies (Basel, Switzerland)

Blood advances

Human vaccines & immunotherapeutics

Uniformed Services University of the Health Sciences

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Uniformed Services University of the Health Sciences

United States

Associate Professor :: Medicine

Publications

Tonia L Conner, Pooja Vir, Eric D Laing, Ian J Stewart, Edward Mitre, Kathleen P Pratt
The Seraph 100 ® Microbind Affinity Blood Filter Does Not Alter Levels of Circulating or Mucosal Antibodies in Critical COVID-19 Patients. Antibodies (Basel, Switzerland) 13 (3) (2024)
Tonia L Conner, Pooja Vir, Eric D Laing, Ian J Stewart, Edward Mitre, Kathleen P Pratt
The Seraph 100 ® Microbind Affinity Blood Filter Does Not Alter Levels of Circulating or Mucosal Antibodies in Critical COVID-19 Patients. Antibodies (Basel, Switzerland) 13 (3) (2024)
Kathleen P Pratt
Factor VIII forges its own path. Blood 142 (3) (2023)
Teodor-D Brumeanu, Pooja Vir, Ahmad Faisal Karim, Swagata Kar, Dalia Benetiene, Megan Lok, Jack Greenhouse, Tammy Putmon-Taylor, Christopher Kitajewski, Kevin K Chung, Kathleen P Pratt, Sofia A Casares
Human-Immune-System (HIS) humanized mouse model (DRAGA: HLA-A2.HLA-DR4.Rag1KO.IL-2RγcKO.NOD) for COVID-19. Human vaccines & immunotherapeutics 18 (5) (2022)
Kathleen P Pratt, Devi Gunasekera, Pooja Vir, Siyuan Tan, Glenn F Pierce, Cara H Olsen, Saulius Butenas, Kenneth G Mann
Anti-FVIII antibodies in Black and White hemophilia A subjects: do F8 haplotypes play a role? Blood advances (2022)
Mirian Mendoza, Devi Gunasekera, Kathleen P Pratt, Qi Qiu, Sofia Casares, Teodor-D Brumeanu
The humanized DRAGA mouse (HLA-A2. HLA-DR4. RAG1 KO. IL-2R g c KO. NOD) establishes inducible and transmissible models for influenza type A infections. Human vaccines & immunotherapeutics 16 (9) (2020)
Ruth A Ettinger, Joseph A Liberman, Devi Gunasekera, Komal Puranik, Eddie A James, Arthur R Thompson, Kathleen P Pratt
FVIII proteins with a modified immunodominant T-cell epitope exhibit reduced immunogenicity and normal FVIII activity. Blood advances 2 (4) (2019)
Kathleen P Pratt
Anti-Drug Antibodies: Emerging Approaches to Predict, Reduce or Reverse Biotherapeutic Immunogenicity. Antibodies (Basel, Switzerland) 7 (2) (2018)
Kathleen P Pratt
Marginal immunogenicity of factor VIII. Blood 130 (23) (2018)
Debargh Dutta, Devi Gunasekera, Margaret V Ragni, Kathleen P Pratt
Accurate, simple, and inexpensive assays to diagnose F8 gene inversion mutations in hemophilia A patients and carriers. Blood advances 1 (3) (2016)
Ruth A Ettinger, Pedro Paz, Eddie A James, Devi Gunasekera, Fred Aswad, Arthur R Thompson, Dana C Matthews, Kathleen P Pratt
T cells from hemophilia A subjects recognize the same HLA-restricted FVIII epitope with a narrow TCR repertoire. Blood 128 (16) (2016)
Kathleen P Pratt
fVIII binds platelets + fibrin: no PS! Blood 126 (10) (2016)
Devi Gunasekera, Ruth A Ettinger, Shelley Nakaya Fletcher, Eddie A James, Maochang Liu, John C Barrett, Janice Withycombe, Dana C Matthews, Melinda S Epstein, Richard J Hughes, Kathleen P Pratt, null null
Factor VIII gene variants and inhibitor risk in African American hemophilia A patients. Blood 126 (7) (2015)

Kathleen P Pratt.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Kathleen P Pratt